| Financial Year |
March 31 2023 |
| Monetary Funds |
198,237,527.36 |
| Held-for-trading Financial Assets |
80,400,000.00 |
| Notes Receivable |
11,242,787.08 |
| Accounts Receivable |
167,804,268.44 |
| Advances to Suppliers |
8,215,238.14 |
| Other Receivables |
2,304,275.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
204,775,963.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,545,424.29 |
| Total Current Assets |
696,114,330.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,278,729.62 |
| Investment Properties |
-- |
| Fixed Assetes |
153,001,615.09 |
| Under-construction Projects |
1,094,814.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,892,602.04 |
| R&D expenses |
15,131,779.68 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
63,598,875.66 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
341,109,592.00 |
| Total Assets |
1,037,223,922.53 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
130,027,896.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,849,436.49 |
| Taxes Payable |
2,206,586.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,752,332.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,633,478.76 |
| Other Current Liabilities |
9,828,434.78 |
| Sub-Total of Current Liabilities |
360,141,167.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,691,155.61 |
| Deferred Income Tax Liabilities |
5,770,257.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,631,655.32 |
| Total Liabilities |
372,772,822.34 |
| Paid-In Capital(Or Share Stock) |
847,208,028.00 |
| Capital Surplus |
2,577,153,452.84 |
| Surplus Reserve |
38,075,914.71 |
| LESS:Treasury Stock |
7,881,000.00 |
| Undistributed Profits |
-2,759,899,873.71 |
| Minority Stockholder's Interest |
-642,121.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
665,093,221.28 |
| Owner's Equity（Stockholder's Equity） |
664,451,100.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,037,223,922.53 |
